Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Sleep Wake Disorders 1Recurrence 1Prostatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Hematologic Neoplasms 1Brain Neoplasms 1

Interventions

Cyclophosphamide 15fludarabine 12Mycophenolic Acid 10Standard of Care 9venetoclax 7Whole-Body Irradiation 7Tacrolimus 7Specimen Handling 7Sirolimus 6Practice Guidelines as Topic 6trametinib 5Melphalan 5Azacitidine 5fludarabine phosphate 4Mesna 4Magnetic Resonance Spectroscopy 4Filgrastim 4Biopsy 4Behavior Therapy 4Thiotepa 3Surveys and Questionnaires 3Peripheral Blood Stem Cell Transplantation 3Interviews as Topic 3GSK2636771 3Educational Status 3Cytarabine 3Crizotinib 3Busulfan 3thymoglobulin 2talquetamab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hematologic Neoplasms × Methylphenidate × 90 days × Clear all
NCT01628029 2026-05-22

Cognitive Behavioral Therapy and Multimodal Therapy in Treating Sleep Disturbance in Patients With Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
68 enrolled 16 charts
Other hematologic neoplasm

Sleep Wake Disorders, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡